immunomed inc said file registr statement with secur and exchang commiss for propos sale 500 000 share common stock compani said will sell 100 000 share and certain stockhold will sell remain 400 000 share proceed from offer will use for product develop basic research staff expans prepay debt capit expenditur and work capit compani said offer will manag hutton and inc and first boston corp immunomed said reuter 